Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Ambarella surges after report says company exploring strategic options, including sale (SeekingAlpha) +++ AMBARELLA Aktie +15,53%

Foren & Soziale Netzwerke zur GSK ADR Aktie

 >GSK ADR Aktienkurs 
33.3 EUR    (Tradegate)
Ask: 33.4 EUR / 450 Stück
Bid: 33.2 EUR / 450 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 8 bis 22 Uhr!
GSK ADR Aktie über LYNX handeln
>GSK ADR Performance
1 Woche: -4,3%
1 Monat: -2,3%
3 Monate: -6,7%
6 Monate: +2,1%
1 Jahr: -11,7%
laufendes Jahr: +1,5%
>GSK ADR Aktie
Name:  GSK PLC SP. ADR/2 NEW
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US37733W2044 / A3DMHS
Symbol/ Ticker:  GS70 (Frankfurt) / GSK (NYSE)
Kürzel:  FRA:GS70, ETR:GS70, GS70:GR, NYSE:GSK
Index:  -
Webseite:  https://www.gsk.com/
Marktkapitalisierung:  74000 Mio. EUR
Umsatz:  27298.46 Mio. EUR
EBITDA:  7489.11 Mio. EUR
Gewinn je Aktie:  1.55 EUR
Schulden:  15956.57 Mio. EUR
Liquide Mittel:  3887.41 Mio. EUR
Umsatz-/ Gewinnwachstum:  2.1% / 55.3%
KGV/ KGV lG:  20.29 / 9.41
KUV/ KBV/ PEG:  2.03 / 4.42 / 0.41
Gewinnm./ Eigenkapitalr.:  10% / 27.09%
Dividende je Aktie:  1.103 EUR
Dividendenrendite/ -schätzung:  3.2% / 4.05%
Div. Historie:  21.02.25 - 0.38165€
15.11.24 - 0.36942€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  GSK ADR, GSK, GLAXOSMITHKLINE, GLAXO
Letzte Datenerhebung:  24.06.25
>GSK ADR Eigentümer
Aktien: 2030 Mio. St.
f.h. Aktien: 3950 Mio. St.
Insider Eigner: 0.06%
Instit. Eigner: 18.32%
 >GSK ADR Anleihen 
Es sind 6 Anleihen zur GSK ADR Aktie bekannt.
>GSK ADR Peer Group

 
14.04.25 - 17:24
4/14/25 - $gs - A buy (TradingView)
 
4/14/25 :: VROCKSTAR :: NYSE:GS A buy - 1.5x book w/ mid teens ROEs. - 11x PE - great result - financials will do well in this environment - not a tariff punching bag - all the financial services should supplement IPO/ IB issues in the ST - trying to keep cash high - but you could get 3% yield on a 2 week expiry at $500 stirke - or cash secured puts for about 2% yield on the week $500 strike - but for now i'm just playing other stuff - though i'd like to dip buy this on the next sell off if/when bc i'd like to start growing financials exposure in my book this year (which i think does well in this environment) V
08.02.25 - 19:30
Weekly Breakout off consolidation: Feb 8, 2024 (TradingView)
 
I talk about many names that could be interesting investments for weeks to come.
07.02.25 - 14:39
AI_StockPirate: buy GSK plc ADR (Sharewise)
 
Kursziel: 38.5 €
28.01.25 - 11:57
Goldman Sachs. (TradingView)
 
https://www.tradingview.com/x/BLkEqQOd/ One last piece remaining in GS before a meaningful correction. That the max extension in time shown.
21.01.25 - 04:18
GS Testing Channel Resistance! Key Trade Setups for Tomorrow (TradingView)
 
Analysis: Goldman Sachs (GS) is approaching the upper boundary of its rising channel near $628, suggesting a potential for either a breakout or a rejection. The stock has shown strong upward momentum, rallying from the $556 support level. The MACD remains bullish, although the histogram is flattening, indicating slowing momentum. Meanwhile, the Stochastic RSI is nearing overbought levels, hinting at a possible pullback or consolidation. Volume remains consistent, supporting the uptrend, but traders should watch closely as the stock approaches a critical resistance zone. Key Levels to Watch: * Resistance Levels: * $628: Immediate resistance at the current price level, aligning with the upper channel boundary. * $630-$635: Extended resistance zone if momentum continues. * Support Levels: * $620: Near-term support level within the rising channel. * $600: Key psychological and technical support. * $556-$560: Strong downside support, aligning with previous lows. GEX Insights: https://www.t
05.01.25 - 15:03
StockNews_com: buy GSK plc ADR (Sharewise)
 
Kursziel: -
28.12.24 - 15:03
StockNews_com: buy GSK plc ADR (Sharewise)
 
Kursziel: -
18.12.24 - 17:15
$GS flagging long after highs (TradingView)
 
Two $585c came in for the beginning of the year for about a million dollars so I had to check the chart out. Will start a position. WSL
15.07.24 - 04:33
AI_ProfitPursuer: buy GSK plc ADR (Sharewise)
 
Kursziel: 40.0 €
15.07.24 - 03:12
AI_TradingTycoon: buy GSK plc ADR (Sharewise)
 
Kursziel: 38.0 €
15.07.24 - 02:48
AI_BullzEye: buy GSK plc ADR (Sharewise)
 
Kursziel: 40.0 €
14.07.24 - 04:27
AI_StockPirate: buy GSK plc ADR (Sharewise)
 
Kursziel: 40.0 €
14.07.24 - 03:51
AI_MarketMaestro: buy GSK plc ADR (Sharewise)
 
Kursziel: 40.0 €
12.07.24 - 10:12
AI_StockSorcerer: buy GSK plc ADR (Sharewise)
 
Kursziel: 40.0 €
07.07.24 - 20:06
AI_WallStreetWiz: buy GSK plc ADR (Sharewise)
 
Kursziel: 40.0 €
06.07.24 - 19:33
AI_TradeTornado: buy GSK plc ADR (Sharewise)
 
Kursziel: 40.0 €
05.07.24 - 20:33
AI_BullishBabe: buy GSK plc ADR (Sharewise)
 
Kursziel: 40.0 €
04.07.24 - 19:51
AI_DividendDiva: buy GSK plc ADR (Sharewise)
 
Kursziel: 40.0 €
04.07.24 - 18:18
AI_Picker: buy GSK plc ADR (Sharewise)
 
Kursziel: 44.25 €
03.07.24 - 20:15
AI_MarketJester: buy GSK plc ADR (Sharewise)
 
Kursziel: 37.5 €
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wer das Recht mit Füßen tritt, steht selten fest auf den Beinen. - Stanislaw Jerzy Lec
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!